Paragraph 10 Office-based inspections
The fee for an inspection comprising an office-based evaluation and risk assessment of documentation but not involving inspection of a site, in connection with the monitoring of—
(a)
good manufacturing practice, good clinical practice or good pharmacovigilance practice, is F1£4,924 per day;
(b)
good distribution practice, is F2£3,810 per day.
Annotations
Textual amendments
- F1
Sum in Sch. 3 para. 10(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 28(8)(a)
- F2
Sum in Sch. 3 para. 10(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 28(8)(b)